Alteration of Glucose Homeostasis in V1a Vasopressin Receptor-Deficient Mice
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Arginine-vasopressin (AVP) is known to be involved in maintaining glucose homeostasis, and AVP-resistance is observed in poorly controlled non-insulin-dependent diabetes mellitus subjects, resulting in a lowered plasma volume. Recently we reported that V1a vasopressin receptor-deficient (V1aR−/−) mice exhibited a decreased circulating blood volume and hypermetabolism of fat accompanied with impaired insulin-signaling. Here we further investigated the roles of the AVP/V1a receptor in regulating glucose homeostasis and plasma volume using V1aR−/− mice. The plasma glucose levels at the baseline or during a glucose tolerance test were higher in V1aR−/− than wild-type (WT) mice. Moreover, a hyperinsulinemic-euglycemic clamp revealed that the glucose infusion rate was significantly lower in V1aR−/− mice than in WT mice and that hepatic glucose production was higher in V1aR−/− mice than WT mice. In contrast to the increased hepatic glucose production, the liver glycogen content was decreased in the mutant mice. These results indicated that the mutant mice had impaired glucose tolerance. Furthermore, feeding V1aR−/− mice a high-fat diet accompanied by increased calorie intake resulted in significantly overt obesity in comparison with WT mice. In addition, we found that the circulating plasma volume and aldosterone level were decreased in V1aR−/− mice, although the plasma AVP level was increased. These results suggested that the effect of AVP on water recruitment was disturbed in V1aR−/− mice. Thus, we demonstrated that one of the AVP-resistance conditions resulting from deficiency of the V1a receptor leads to decreased plasma volume as well as impaired glucose homeostasis, which can progress to obesity under conditions of increased calorie intake.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mice lacking the V1aR display impaired glucose tolerance, insulin resistance and elevated AVP levels20”
From Plasma Copeptin and the Risk of Diabetes Mellitus (2010) · cites this paper as [20]
In the citing paper
“The finding that mice with deleted V1aR and/or V1bR exhibit metabolic disorders [12][13][14][15] has prompted several epidemiological investigations in humans.”
From Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats (2015) · cites this paper as [12]
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans
Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., Ohannesian, J. P., Marco, C. C., McKee, L. J., Bauer, T. L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340503 · Cited by 6,326
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689
Frederich, R. C., Hamann, A., Anderson, S., Löllmann, B., Lowell, B. B., & Flier, J. S. (1995) · Nature Medicine · doi:10.1038/nm1295-1311 · Cited by 1,660
Atrial natriuretic factor—a circulating hormone stimulated by volume loading
Lang, R. E., Thölken, H., Ganten, D., Luft, F. C., Ruskoaho, H., & Unger, T. (1985) · Nature · doi:10.1038/314264a0 · Cited by 1,230
Impact of Obesity on Plasma Natriuretic Peptide Levels
Wang, T. J., Larson, M. G., Levy, D., Benjamin, E. J., Leip, E. P., Wilson, P. W. F., & Vasan, R. S. (2004) · Circulation · doi:10.1161/01.cir.0000112582.16683.ea · Cited by 1,022
Natriuretic peptides: a new lipolytic pathway in human adipocytes
Sengenès, C., Berlan, M., de Glisezinski, I., Lafontan, M., & Galitzky, J. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.10.1345 · Cited by 532
Lolait, S. J., O'Carroll, A.-M., McBride, O. W., Konig, M., Morel, A., & Brownstein, M. J. (1992) · Nature · doi:10.1038/357336a0 · Cited by 524
Molecular cloning and expression of a rat Via arginine vasopressin receptor
Morel, A., O'Carroll, A.-M., Brownstein, M. J., & Lolaft, S. J. (1992) · Nature · doi:10.1038/356523a0 · Cited by 477
Glucose Inhibition of the Glucose-sensitive Neurone in the Rat Lateral Hypothalamus
OOMURA, Y., OOYAMA, H., SUGIMORI, M., NAKAMURA, T., & YAMADA, Y. (1974) · Nature · doi:10.1038/247284a0 · Cited by 358
Cited by
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Vasopressin: Behavioral roles of an “original” neuropeptide
Caldwell, H. K., Lee, H.-J., Macbeth, A. H., & Young, W. S. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.10.007 · Cited by 504
“, 2006) and impaired lipid metabolism and glucose homeostasis (Aoyagi et al., 2007; Hiroyama et al., 2007).”
BackgroundVasopressin V1a and V1b Receptors: From Molecules to Physiological Systems
Koshimizu, T.-A., Nakamura, K., Egashira, N., Hiroyama, M., Nonoguchi, H., & Tanoue, A. (2012) · Physiological Reviews · doi:10.1152/physrev.00035.2011 · Cited by 407
“Because V1aR-KO mice are glucose intolerant and resistant to insulin-mediated glucose uptake (26), it can be speculated that the hypermetabolism of fat is a compensatory mechanism for the reduced capacity to use glucose as an energy source.”
BackgroundMethodResultInfluentialSelf-citationPlasma Copeptin and the Risk of Diabetes Mellitus
Enhörning, S., Wang, T. J., Nilsson, P. M., Almgren, P., Hedblad, B., Berglund, G., Struck, J., Morgenthaler, N. G., Bergmann, A., Lindholm, E., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.909663 · Cited by 299
Kohno, D., Nakata, M., Maejima, Y., Shimizu, H., Sedbazar, U., Yoshida, N., Dezaki, K., Onaka, T., Mori, M., & Yada, T. (2008) · Endocrinology · doi:10.1210/en.2007-1276 · Cited by 258
Metadata
- Authors
- Aoyagi, T., Birumachi, J.-I., Hiroyama, M., Fujiwara, Y., Sanbe, A., Yamauchi, J., & Tanoue, A.
- Affiliations
- National Research Institute for Child Health and Development (JP)
- Corresponding author
- Tanoue, Akito
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2007-05-01
- Volume
- 148
- Issue
- 5
- Pages
- 2075-2084
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W1964228140
- Semantic Scholar
- f9abd80b89e1d27908cc1c182452cb2cd575de1d
- Cited by
- 113
- References
- 53
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 5 · 2023: 5 · 2022: 5 · 2021: 6 · 2020: 5 · 2019: 7 · 2018: 4 · 2017: 4 · 2016: 11 · 2015: 9 · 2014: 5 · 2013: 2 · 2012: 6
- FWCI
- 7.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- vasopressin V1a receptor, vasopressin, glucose homeostasis, glucose tolerance, hepatic glucose production, liver glycogen, plasma volume, aldosterone, obesity, high-fat diet, insulin signaling, type 2 diabetes
- MeSH terms
- Animals, Arginine Vasopressin, Blood Glucose, Body Weight, Energy Intake, Dietary Fats, Feeding Behavior, Glycogen, Homeostasis, Insulin, Liver, Male, Mice, Inbred C57BL, Mice, Mutant Strains, Obesity, Plasma Volume, Receptors, Vasopressin, Leptin, Metabolic Syndrome, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alteration of Glucose Homeostasis in V1a Vasopressin Receptor-Deficient Mice. https://app.cochat.ai/papers/10.1210/en.2006-1315
- The paper
- Aoyagi, T., Birumachi, J.-I., Hiroyama, M., Fujiwara, Y., Sanbe, A., Yamauchi, J., & Tanoue, A. (2007). Alteration of Glucose Homeostasis in V1a Vasopressin Receptor-Deficient Mice. Endocrinology. https://doi.org/10.1210/en.2006-1315
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.